Protagenic Therapeutics, Inc. Warrant 2021-13.04.25 on Protagenic Thera PTIXW 深 沪
等待开盘 10-29 09:30:00 美东时间
0.0366
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 4474股
- 最 低 --
- 昨 收 0.0366
- 总市值 37.56万
- 52周最高 0.49
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.001
- 委 比 -81.95%
- 总股本 1026.14万
- 历史最高 0.80
- 量 比 6.87
- 振 幅 0.00%
- 历史最低 0.001
- 每 手 1
- 风险率 0.03%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Protagenic Therapeutics May Offer And Sell Shares Of Common Stock Of Up To $1.75M
-SEC Filing
10-25 05:44
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers ModivCare (NASDAQ:MODV) stock increased by 69.6% to $0.95 during Frida...
08-22 20:08
Protagenic Therapeutics (PTIX) Shares Surge On Clinical Trial Progress
Shares of Protagenic Therapeutics are trading sharply higher Thursday afternoon. The stock soared over 100% midday after the company announced a key clinical milestone.
08-22 03:32
Protagenic Completes First Dose Injections In Phase I Multiple-Dose Study Of PT00114; Topline Safety Data Expected By September; Phase 2 Launch Targeted For Q1 2026
Dosing Completion Expected by End of August; Phase 2 Trial Expected to Begin in 1Q 2026NEW YORK, NY / ACCESS Newswire / August 21, 2025 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a biopharmaceutical company
08-21 20:16
Protagenic Therapeutics Restructures to Focus on PT00114
Protagenic Therapeutics ( ($PTIX) ) just unveiled an announcement. On August 8,...
08-14 05:58
Protagenic Therapeutics Appoints Timothy Wright to Board
The latest update is out from Protagenic Therapeutics ( ($PTIX) ). On July 18, ...
07-25 00:58
Protagenic Therapeutics Announces Share Purchase Rights Distribution
Protagenic Therapeutics ( ($PTIX) ) has provided an announcement. On June 24, 2...
06-28 05:53
Protagenic Therapeutics Issues Common Stock for Warrants
The latest announcement is out from Protagenic Therapeutics ( ($PTIX) ). Protag...
05-21 00:18
Protagenic Therapeutics (PTIX) Stock Soars 240% On Phytanix Merger
Protagenic Therapeutics shares soared 240% Monday on its all-stock merger with Phytanix Bio. New Phytanix targets CNS disorders with an expanded diverse pipeline and experienced team.
05-20 00:09
